Related Experiment Video

Updated: Jun 8, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on: April 29, 2014

Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma

Gorka Larrinaga1, Begoña Sanz, Itxaro Pérez

  • 1Department of Physiology, Faculty of Medicine and Dentistry, University of the Basque Country, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Leioa, Bizkaia, Spain.

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|September 21, 2010
PubMed

Insights

Cannabinoids show anti-tumor effects, but clear cell renal cell carcinoma (CCRCC) downregulates cannabinoid (CB) receptor CB₁ protein and lacks CB₂ expression, suggesting a role for the endocannabinoid system in kidney cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cannabinoids exhibit significant antitumoral properties demonstrated in preclinical studies.
  • Cannabinoid (CB) receptors, specifically CB₁ and CB₂, are key mediators of these effects.
  • Investigating CB receptor expression in human neoplasms is crucial for understanding their role in cancer.

Purpose of the Study:

  • To analyze the expression of CB₁ and CB₂ receptors in clear cell renal cell carcinoma (CCRCC).
  • To determine the potential involvement of the endocannabinoid system in renal carcinogenesis.

Main Methods:

  • Prospective collection of 20 CCRCC tissue samples.
  • Analysis of CB receptor expression using RT-PCR, Western blot (WB), and immunohistochemistry (IHC).

Main Results:

  • CB₁ mRNA was detected in both tumor and adjacent non-neoplastic kidney tissue.
  • WB and IHC revealed a significant downregulation of CB₁ protein in CCRCC tissue.
  • CB₂ receptor expression was absent in CCRCC tissue.

Conclusions:

  • CCRCC is characterized by posttranscriptional downregulation of CB₁ and the absence of CB₂ expression.
  • These findings suggest a potential role for the endocannabinoid system in the development of renal cell carcinoma.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...